Human serum or plasma concentrations of total chemerin (measure of inactive and active chemerin forms) correlates with markers of inflammation, are elevated in individuals with obesity, coronary artery disease, insulin-resistance, early onset and long-term type 2 diabetes and hypertension [10]–[24]. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.